Louise C. Connell

2.6k total citations · 1 hit paper
31 papers, 1.6k citations indexed

About

Louise C. Connell is a scholar working on Oncology, Hepatology and Surgery. According to data from OpenAlex, Louise C. Connell has authored 31 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 16 papers in Hepatology and 15 papers in Surgery. Recurrent topics in Louise C. Connell's work include Hepatocellular Carcinoma Treatment and Prognosis (14 papers), Colorectal Cancer Treatments and Studies (12 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers). Louise C. Connell is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (14 papers), Colorectal Cancer Treatments and Studies (12 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers). Louise C. Connell collaborates with scholars based in United States, Ireland and Netherlands. Louise C. Connell's co-authors include Mario E. Lacouture, David B. Page, Michael A. Postow, Jedd D. Wolchok, Bob T. Li, Jarushka Naidoo, Katja Schindler, Paulo M. Hoff, Maria Ignez Braghiroli and José Maurício Mota and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Surgery and Clinical Cancer Research.

In The Last Decade

Louise C. Connell

25 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies

2015 1.2k citations Jarushka Naidoo, David B. Page et al. Annals of Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Louise C. Connell United States	8	1.2k	376	347	242	211	31	1.6k
Mehmet Akce United States	16	847 0.7×	184 0.5×	255 0.7×	187 0.8×	275 1.3×	115	1.2k
Pierre Combe France	13	916 0.8×	473 1.3×	432 1.2×	373 1.5×	165 0.8×	42	1.5k
Michail Doukas Netherlands	18	784 0.7×	363 1.0×	344 1.0×	279 1.2×	521 2.5×	108	1.6k
Anwaar Saeed United States	18	964 0.8×	167 0.4×	365 1.1×	280 1.2×	386 1.8×	167	1.4k
Hongnan Mo China	17	1.0k 0.8×	381 1.0×	427 1.2×	372 1.5×	223 1.1×	54	1.5k
Olivier Dubreuil France	15	932 0.8×	259 0.7×	498 1.4×	310 1.3×	378 1.8×	56	1.6k
Wenzhuo He China	19	878 0.7×	250 0.7×	279 0.8×	241 1.0×	296 1.4×	84	1.3k
Hiroshi Ariyama Japan	20	804 0.7×	280 0.7×	290 0.8×	426 1.8×	259 1.2×	84	1.4k
Yoon Dae Han South Korea	19	774 0.6×	240 0.6×	231 0.7×	201 0.8×	418 2.0×	90	1.2k
Francesco De Rosa Italy	18	694 0.6×	392 1.0×	168 0.5×	291 1.2×	150 0.7×	58	1.1k

Countries citing papers authored by Louise C. Connell

Since Specialization

Citations

This map shows the geographic impact of Louise C. Connell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Louise C. Connell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Louise C. Connell more than expected).

Fields of papers citing papers by Louise C. Connell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Louise C. Connell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Louise C. Connell. The network helps show where Louise C. Connell may publish in the future.

Co-authorship network of co-authors of Louise C. Connell

This figure shows the co-authorship network connecting the top 25 collaborators of Louise C. Connell. A scholar is included among the top collaborators of Louise C. Connell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Louise C. Connell. Louise C. Connell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Merkow, Ryan P., Michael J. Cavnar, Ana Gleisner, et al.. (2025). Minimum Requirements to Safely Establish and Sustain New Hepatic Arterial Infusion Pump Programs: An International Expert Perspective. Annals of Surgical Oncology. 32(6). 4408–4416.

Sotirchos, Vlasios S., Mikhail Silk, Juan C. Camacho, et al.. (2025). Selective intra-arterial mitomycin-C infusions for treatment-refractory colorectal liver metastases. Journal of Gastrointestinal Oncology. 16(1). 92–105.

Sotirchos, Vlasios S., Adam Mitchell, Elena N. Petre, et al.. (2025). Tumor Absorbed Dose Predicts Survival and Local Tumor Control in Colorectal Liver Metastases Treated with 90Y Radioembolization. CardioVascular and Interventional Radiology. 49(1). 73–86.

Connell, Louise C. & Nancy E. Kemeny. (2024). Intraarterial Chemotherapy for Liver Metastases. Hematology/Oncology Clinics of North America. 39(1). 143–159.

Chapuis, Pierre H., et al.. (2024). Lymph node ratio prognosticates overall survival in patients with stage IV colorectal cancer. Techniques in Coloproctology. 28(1). 115–115.

Soares, Kevin C., Joshua S. Jolissaint, Kenneth Seier, et al.. (2023). Hepatic disease control in patients with intrahepatic cholangiocarcinoma correlates with overall survival. Cancer Medicine. 12(11). 12272–12284. 4 indexed citations

Segal, Neil H., Andrea Cercek, Rona Yaeger, et al.. (2022). Simplified Graded Infusion Strategy for Mitigation of Oxaliplatin Hypersensitivity. Clinical Colorectal Cancer. 21(2). 149–153. 2 indexed citations

Jolissaint, Joshua S., Kevin C. Soares, Kenneth Seier, et al.. (2021). Intrahepatic Cholangiocarcinoma with Lymph Node Metastasis: Treatment-Related Outcomes and the Role of Tumor Genomics in Patient Selection. Clinical Cancer Research. 27(14). 4101–4108. 30 indexed citations

Boerner, Thomas, Constantinos P. Zambirinis, Johan Gagnière, et al.. (2020). Early liver metastases after “failure” of adjuvant chemotherapy for stage III colorectal cancer: is there a role for additional adjuvant therapy?. HPB. 23(4). 601–608. 4 indexed citations

10.

Connell, Louise C. & Nancy E. Kemeny. (2020). Intraarterial Chemotherapy for Liver Metastases. Surgical Oncology Clinics of North America. 30(1). 143–158. 7 indexed citations

11.

Gholami, Sepideh, S.M. Stewart, Nancy E. Kemeny, et al.. (2020). Impact of Primary Tumor Laterality on Adjuvant Hepatic Artery Infusion Pump Chemotherapy in Resected Colon Cancer Liver Metastases: Analysis of 487 Patients. Annals of Surgical Oncology. 28(7). 3685–3694. 4 indexed citations

12.

Cercek, Andrea, Zsofia K. Stadler, Jenna Sinopoli, et al.. (2020). A phase II study of induction PD-1 blockade in subjects with locally advanced mismatch repair-deficient rectal adenocarcinoma.. Journal of Clinical Oncology. 38(15_suppl). TPS4123–TPS4123. 3 indexed citations

13.

Smith, J. Joshua, Walid K. Chatila, Francisco Sánchez-Vega, et al.. (2019). Genomic stratification beyond Ras/B‐Raf in colorectal liver metastasis patients treated with hepatic arterial infusion. Cancer Medicine. 8(15). 6538–6548. 8 indexed citations

14.

Latham, Alicia, Diane Reidy‐Lagunes, Neil H. Segal, et al.. (2019). Characterization and clinical outcomes of mismatch repair deficient (dMMR) small bowel adenocarcinoma (SBA).. Journal of Clinical Oncology. 37(15_suppl). 1511–1511. 2 indexed citations

15.

Connell, Louise C., José Maurício Mota, Maria Ignez Braghiroli, & Paulo M. Hoff. (2017). The Rising Incidence of Younger Patients With Colorectal Cancer: Questions About Screening, Biology, and Treatment. Current Treatment Options in Oncology. 18(4). 23–23. 158 indexed citations

16.

Connell, Louise C., James J. Harding, & Ghassan K. Abou‐Alfa. (2016). Advanced Hepatocellular Cancer: the Current State of Future Research. Current Treatment Options in Oncology. 17(8). 43–43. 50 indexed citations

17.

Connell, Louise C., James J. Harding, Jinru Shia, & Ghassan K. Abou‐Alfa. (2016). Combined intrahepatic cholangiocarcinoma and hepatocellular carcinoma. Chinese Clinical Oncology. 5(5). 66–66. 31 indexed citations

18.

Naidoo, Jarushka, David B. Page, Bob T. Li, et al.. (2015). Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies. Annals of Oncology. 26(12). 2375–2391. 1186 indexed citations breakdown →

19.

Connell, Louise C., James J. Harding, Maeve A. Lowery, et al.. (2015). Platinum-based combination therapy (PCT) and outcomes for patients (pts) with mixed hepatocellular carcinoma and intrahepatic cholangiocarcinoma (mHCC/ICC).. Journal of Clinical Oncology. 33(15_suppl). e15146–e15146. 2 indexed citations

20.

Connell, Louise C., et al.. (2012). Does age count in pancreatic resection? An Irish experience.. Journal of Clinical Oncology. 30(4_suppl). 348–348. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact